Hallmarks of tumor-associated microglia response to experimental U87 human glioblastoma xenograft

Tihomir Dugandžija1, Jovana Drljača2, Dragica Bulajić2

  • 1Faculty of Medicine, Department of Epidemiology, University of Novi Sad, Hajduk Veljkova 3, Novi Sad, 21000, Serbia; Oncology Institute of Vojvodina, Put doktora Goldmana 4, Sremska Kamenica, 21204, Serbia.

Tissue & Cell
|May 29, 2021
PubMed

Insights

Tumor-associated microglia (TAM) infiltrate glioblastoma (GBM) early and proliferate, correlating with tumor growth. These microglia change shape within the tumor, suggesting a role in GBM progression and offering a potential therapeutic target.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Biology

Background:

  • Glioblastoma (GBM) is a highly aggressive brain tumor.
  • Tumor-associated microglia/macrophages (TAM) are key components of the GBM microenvironment.
  • Understanding TAM kinetics and characteristics is crucial for developing novel therapies.

Purpose of the Study:

  • To histopathologically characterize TAM and their infiltration kinetics in an orthotopic U87 GBM model.
  • To evaluate TAM proliferation and morphological changes during GBM progression.
  • To correlate TAM density with tumor growth and vascularization.

Main Methods:

  • Orthotopic U87 GBM xenograft model in rodents.
  • Histopathological analysis of TAM at three distinct time points post-inoculation.
  • Assessment of TAM morphology, density, proliferation, and co-localization with blood vessels.

Main Results:

  • TAM infiltration and proliferation were observed early after GBM initiation, peaking at 7 days.
  • TAM density positively correlated with GBM growth and proliferation.
  • Microglia exhibited morphological changes, transitioning from ramified to ameboid shapes within the tumor core.
  • Increased TAM density was associated with a higher blood vessel fraction.

Conclusions:

  • The U87 GBM model effectively recapitulates TAM infiltration and dynamic changes.
  • Microglia play a significant role in GBM progression, exhibiting pro-invasive features.
  • Targeting microglia presents a promising therapeutic strategy for glioblastoma.

Related Concept Videos